Kevin Sayer has been appointed to serve as chief operating officer at DexCom. The COO post is in addition to Sayer's current role as president of the San Diego, Calif.-based glucose monitoring device firm.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan